Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Assets (2009 - 2026)

Updated

Teva Pharmaceutical Industries' Assets came in at $39.86 billion for Q2 2026, down 0.7% from $40.13 billion a year earlier and down 0.5% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Teva Pharmaceutical Industries' Assets was $40.75 billion, up 3.6% from FY2024.

  • Assets carries a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
  • Going back by year, Assets was $39.33 billion in FY2024 (-9.6%), $43.48 billion in FY2023 (-1.2%), $44.01 billion in FY2022 (-7.7%) and $47.67 billion in FY2021 (-5.9%).
  • The five-year range for quarterly Assets is $38.42 billion (Q1 2025) to $47.85 billion (Q3 2021).
  • Year-over-year, Assets increased in two of the last eight quarters, with an average decline of 2.6%.
  • The fastest year-over-year change in Assets over five years came in Q1 2026 (growth of 4.2%), and the weakest in Q1 2025 (a decline of 10.2%).
  • Business Quant data shows TEVA's Assets at $40.04 billion (Q1 2026), $40.75 billion (Q4 2025) and $39.86 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 201.06 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 135.12 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 115.83 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 49.36 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 27.42 Bn
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 39.86 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.86 Bn
Mar 31, 2026 40.04 Bn
Dec 31, 2025 40.75 Bn
Sep 30, 2025 39.86 Bn
Jun 30, 2025 40.13 Bn
Mar 31, 2025 38.42 Bn
Dec 31, 2024 39.33 Bn
Sep 30, 2024 41.76 Bn
Jun 30, 2024 41.34 Bn
Mar 31, 2024 42.77 Bn
Dec 31, 2023 43.48 Bn
Sep 30, 2023 42.10 Bn
Jun 30, 2023 43.10 Bn
Mar 31, 2023 43.46 Bn
Dec 31, 2022 44.01 Bn
Sep 30, 2022 44.25 Bn
Jun 30, 2022 45.93 Bn
Mar 31, 2022 47.06 Bn
Dec 31, 2021 47.67 Bn
Sep 30, 2021 47.85 Bn
API Access

Teva Pharmaceutical Industries Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=TEVA&period=max&api_key=YOUR_API_KEY